December 22, 2025- ZOLL® announced the U.S. launch of the next generation LifeVest wearable cardioverter defibrillator (WCD). This marks the fifth FDA-approved LifeVest WCD, which works seamlessly with the recently launched next generation LifeVest WCD garment, the most comfortable LifeVest WCD ever.
Backed by decades of continuous innovation informed by patient feedback, LifeVest continues to set the standard in the WCD market. LifeVest delivers highly effective, safe therapy for patients at risk of sudden cardiac death with the highest rates of WCD patient compliance based on peer-reviewed publications and real-world data.